Plesiomonas shigelloides is a Gram-negative bacterium classified within the family Enterobacteriaceae. First identified in the 1950s, this organism is primarily associated with aquatic environments and has since been recognized for its potential pathogenicity in humans. Plesiomonas shigelloides is implicated in gastrointestinal infections, particularly in individuals with compromised immune systems or underlying health conditions. Its ability to cause disease, combined with its environmental presence, has made it a subject of interest in microbiology and infectious disease research. As a biomarker, Plesiomonas shigelloides plays a crucial role in the assessment of gastrointestinal health, helping to elucidate the microbial dynamics associated with various diseases and informing diagnostic approaches in clinical settings.

Elevated levels of Plesiomonas shigelloides may indicate a potential imbalance in intestinal microbiota, often associated with gastrointestinal distress or infection. This increase can suggest an overgrowth that may arise from environmental factors such as contaminated water or food. Conversely, low levels of Plesiomonas shigelloides may reflect a healthy gut environment with balanced microbial communities, or it could indicate overall dysbiosis if accompanied by symptoms of gastrointestinal issues. Maintaining appropriate levels of this marker is crucial, as both extremes can signal underlying health concerns that may need to be addressed for optimal gut health.

Plesiomonas shigelloides is featured in the Gut Zoomer panel, a comprehensive test that assesses a wide array of gut microbiota and their roles in health and disease. This marker is particularly relevant as it helps identify potential pathogenic strains that can influence gastrointestinal health. By including Plesiomonas shigelloides in the Vibrant Wellness Test, practitioners can gain insights into microbial balance and potential dysbiosis, enabling more targeted and effective strategies for restoring gut health and overall wellbeing.